Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if adding nivolumab to radiation therapy and bevacizumab can
increase the effectiveness of the treatment for recurrent glioblastoma.